1,567
edits
m (→Outcomes) |
|||
Line 129: | Line 129: | ||
===Adverse Events=== | ===Adverse Events=== | ||
''There was no difference in serious adverse event, bleeding, rate or site of superinfection, new onset sepsis or septic shock, or neurologic sequelae'' | |||
; ≥1 Episode of blood glucose levels ≥8.3 mmol/L [≥150 mg/dl] by day 7 | |||
: 83% vs. 89% (RR 1.07; 95% CI 1.03–1.12; P=0.002) | |||
; Days without blood glucose levels ≥8.3 mmol/L [≥150 mg/dl] by day 7 | |||
: Mean 3.4±2.5 vs. 4.3±2.5 (P<0.001) | |||
: Median 3(1–6) vs. 5(2–6) | |||
==Criticisms== | ==Criticisms== |
edits